Association of HLA-DR genotypes and IL-1 ra gene polymorphism with treatment failure of budesonide and disease patterns in Crohn's disease

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 12, 2001, Pages 1431-1437

  Gelbmann, Cornelia M ^a   Rogler, Gerhard ^a   Gierend, Michael ^b   Gross, Volker ^c   Schölmerich, Jürgen ^a   Andus, Tilo ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Medicomp   (Germany)

^c KLINIKUM ST MARIEN   (Germany)

Author keywords

Budesonide; Crohn's disease; Disease heterogeneity; HLA DR; Interleukin 1 receptor antagonist; Prognostic factors; Steroid resistance

Indexed keywords

BUDESONIDE; HLA DR ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PREDNISOLONE; STEROID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FISTULA; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; CROHN DISEASE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; PATIENT SELECTION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SIALOGLYCOPROTEINS; TREATMENT FAILURE;

EID: 0035216215     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200112000-00006     Document Type: Article

References (33)

1. Ulcerative colitis and Crohn's disease - Susceptibility genes and clinical patterns
2. Inflammatory bowel disease: Progress toward a gene
3. Genetic susceptibility in Crohn's disease - Review of clinical studies
4. Imbalance of the interleukin 1 system in colonic mucosa - Association with intestinal inflammation and interleukin 1 receptor antagonist genotype 2
5. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation
6. A simple classification of Crohn's disease: Report of the working party for the world congresses of gastroenterology, Vienna 1998
7. Reliability of a Crohn's disease clinical classification scheme based on disease behavior
8. Diagnostic approach to IBD
9. European cooperative Crohn's disease study (ECCDS): Results of drug treatment
10. National cooperative Crohn's disease study: Results of drug treatment
11. Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European cooperative Crohn's disease study IV
12. The Israeli budesonide study group. Budesonide versus prednisone in the treatment of active Crohn's disease
13. A comparison of budesonide with prednisolone for active Crohn's disease
14. Frequency of glucocorticold resistance and dependency in Crohn's disease
15. Mesalamine in Crohn's disease with steroid-induced remission: Effect of steroid withdrawal and remission maintenance
16. Endoscopic monitoring of Crohn's disease treatment: A prospective, randomized clinical trial
17. Steroid dependency in Crohn's disease
18. Oral budesonide is as effective as oral prednisolone in active Crohn's disease
19. Oral budesonide for active Crohn's disease
20. Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease
21. A comparison of budesonide and mesalamine for active Crohn's disease
22. Dose-finding study with oral budesonide in patients with active Crohn's ileocolitis
23. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization
24. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes
25. HLA-DRB1*03, but not the TNFA-308 promoter gene polymorphism, confers protection against fistulising Crohn's disease
26. Clinical characteristics of Crohn's disease in 72 families
27. Perforating and non-perforating indications for repeated operations in Crohn's disease: Evidence for two clinical forms
28. Clinical patterns in Crohnrs disease: A statistical study of 615 cases
29. Genetics of inflammatory bowel disease The candidate gene approach: Susceptibility versus disease heterogeneity
30. HLA class II gene frequencies in Crohn's disease: A population based analysis in Germany
31. Association of HLA class II genes with susceptibility to Crohn's disease
32. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease